Increasing the Capacity of the Southern Province Health Office (SPHO) to Provide Comprehensive and Sustainable HIV and AIDS Prevention, Care and Treatment Support in the Republic of Zambia under PEPFAR | CDC RFA GH17 1767

Opportunity Information: Apply for CDC RFA GH17 1767

This grant opportunity, titled "Increasing the Capacity of the Southern Province Health Office (SPHO) to Provide Comprehensive and Sustainable HIV and AIDS Prevention, Care and Treatment Support in the Republic of Zambia under PEPFAR," is a U.S. Centers for Disease Control and Prevention (CDC) cooperative agreement designed to strengthen the Southern Provincial Health Office in Zambia so it can deliver more comprehensive, effective, and sustainable HIV services. It sits within the broader U.S. President's Emergency Plan for AIDS Relief (PEPFAR) portfolio and is aligned with PEPFAR's shift toward more data-driven programming, meaning resources and interventions are intended to be targeted to the geographic areas and population groups with the highest HIV burden in order to maximize impact and accelerate progress toward epidemic control.

The core purpose of the program is capacity building for SPHO, with an emphasis on expanding and improving a combination of prevention, treatment, and care services that have proven to be both effective in reducing new infections and efficient in saving lives. Rather than focusing on a single intervention, the opportunity supports a package of services across the HIV continuum, reinforcing the idea that epidemic control requires coordinated prevention, timely diagnosis, rapid treatment initiation, and long-term retention in care, all backed by reliable laboratory systems and strategic use of program data.

Key programmatic areas called out for continued support include antiretroviral therapy (ART), which is central to reducing HIV-related illness and death and also reduces onward transmission when viral suppression is achieved. It also prioritizes prevention of mother-to-child transmission (PMTCT), a cornerstone intervention for eliminating pediatric HIV by ensuring pregnant and breastfeeding women have access to HIV testing, treatment, and appropriate clinical follow-up. The opportunity specifically highlights counseling and HIV testing for all tuberculosis (TB) patients, reflecting the high overlap between TB and HIV and the public health need to routinely identify and treat HIV among people presenting with TB.

On the prevention side, the opportunity includes voluntary medical male circumcision (VMMC), which is recognized as an evidence-based biomedical intervention that lowers the risk of female-to-male HIV transmission and is often used as part of combination prevention in high-burden settings. HIV testing services (HTS/HTC) are also emphasized, since diagnosis is the entry point to treatment and prevention services; improved testing strategies are consistent with PEPFAR's push to use data to focus testing where it is most likely to identify undiagnosed infections. The grant further supports targeted interventions for key populations, signaling attention to groups that may face higher HIV risk and barriers to care due to stigma, discrimination, or limited access to tailored services. Finally, strengthening laboratory services is included to ensure that HIV care and treatment programs are clinically sound and sustainable, including the testing and monitoring capacity needed to support ART programs and overall quality of care.

From an administrative standpoint, the opportunity is a discretionary funding announcement (Funding Opportunity Number: CDC RFA GH17 1767) offered as a cooperative agreement, which typically indicates substantial involvement by CDC in program implementation, technical support, monitoring, and evaluation. The activity category is health under CFDA 93.067. The program was structured to make one award, with an award ceiling of $7,000,000. The original closing date listed was October 31, 2016, and the responsible agency component is CDC's Center for Global Health (CGH). The work is centered on the Southern Provincial Health Office in Zambia, with the overall intent of helping provincial systems manage and sustain a high-performing HIV response that is better targeted, better measured, and more capable of maintaining gains over time.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Increasing the Capacity of the Southern Province Health Office (SPHO) to Provide Comprehensive and Sustainable HIV and AIDS Prevention, Care and Treatment Support in the Republic of Zambia under PEPFAR" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2016-08-26.
• Applicants must submit their applications by 2016-10-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $7,000,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others.

Apply for CDC RFA GH17 1767

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: